Reinforces combined pharmacological and revascularization strategies in high-risk diabetic IHD patients; extends RCT evidence for targeted management.
Ischemic heart disease IHD is a rapidly increasing common cause of death in the world. This disease is the insufficient status of oxygen within the cardiac muscles due to an imbalance between oxygen supply and demand, and a cardiac disease that occurs as a result of coronary artery stenosis. Ischemic heart disease diseases are the leading cause of death in both developed and developing countries ,among these IHD is the most prevalent manifestation and is associated with high mortality and morbidity. The clinical presentation of IHD include silent ischaemia, stable angina, unstable angina, myocardial infarction, heart failure and sudden death.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2022) conducted a review in Ischemic Heart Disease. Pharmacological therapy and revascularization was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: